New Appointments Reinforce Operational Readiness Across Finance, Regulatory Affairs, and Program Leadership Phio ...

Cell sorting has become a key technique in modern biology, medicine, and biotechnology. Researchers use it to separate, analyze, and study different cell types with high precision. In this article, we ...

Scientists discovered that rearranging a peptide’s placement in a spherical nucleic acid vaccine dramatically improves immune response against HPV-driven tumors. The findings have the potential to ...

Patients with resected Merkel cell carcinoma residing in Medicaid expansion states had greater survival rates than those in nonexpansion states.

That track record is fueling a concentrated push among clinical-stage oncology companies toward registration-directed study designs in high-unmet-need tumor types, as demonstrated by Oncolytics ...

ExCellThera, along with its wholly owned subsidiary Cordex Biologics, has received Status 1 listing from the NUB programme in ...

Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...

The findings will be published today (February 11) in Science Advances.

FDA clearance covers pembrolizumab plus paclitaxel ± bevacizumab for PD-L1 CPS ≥1 platinum-resistant disease after one or two prior systemic regimens, introducing PD-1 inhibition into this treatment ...

Incyte Corporation INCY reported fourth-quarter 2025 adjusted earnings of $1.80 per share, which missed the Zacks Consensus Estimate of $1.94, primarily due to higher operating expenses. The company ...